Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-180,200
Closed -$2.63M 10562
2024
Q4
$2.63M Buy
+180,200
New +$2.81M ﹤0.01% 4453
2021
Q3
Sell
-25,000
Closed -$383K 9896
2021
Q2
$383K Buy
+25,000
New +$389K ﹤0.01% 4914
2016
Q1
Sell
-58,000
Closed -$1.94M 7991
2015
Q4
$1.94M Buy
58,000
+57,900
+57,900% +$2.15M ﹤0.01% 2817
2015
Q3
$4K Hold
100
﹤0.01% 7831
2015
Q2
$5K Sell
100
-62,700
-100% -$3.22M ﹤0.01% 7875
2015
Q1
$3.14M Sell
62,800
-230,000
-79% -$12.5M ﹤0.01% 2503
2014
Q4
$19.2M Buy
+292,800
New +$20.4M 0.01% 1013

Other funds holding NOV

UBS Group's NOV Position: Q1 2026 in Review

UBS Group increased its NOV (NOV) stake by 75% in Q1 2026, buying an estimated $8.65M and bringing the position to 1,071,803 shares worth $20.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2575.

UBS Group first reported a position in NOV in Q4 2014 and has held it in 46 quarters since. The position peaked at $104M in Q4 2014. 464 funds tracked by Wall St. Rank hold NOV as of Q1 2026.

  • UBS Group held 1,071,803 shares of NOV worth $20.2M as of Q1 2026.
  • UBS Group bought 460,678 NOV shares in Q1 2026, an estimated $8.65M.
  • NOV made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2575 holding.
  • UBS Group first reported a position in NOV in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's NOV position peaked at $104M in Q4 2014.
  • 464 funds tracked by Wall St. Rank held NOV as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.